Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda - Wikidata - awgldk - TriplyDB

Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda

Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda

http://www.wikidata.org/entity/Q36411652

about

The influence of pregnancy on the pharmacokinetic properties of artemisinin combination therapy (ACT): a systematic review Preliminary pharmaceutical development of antimalarial-antibiotic cotherapy as a pre-referral paediatric treatment of fever in malaria endemic areas.Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso.Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania.Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.Malaria: an update on current chemotherapy.Treating severe malaria in pregnancy: a review of the evidence Modelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challenges Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.Artemether-lumefantrine co-administration with antiretrovirals: population pharmacokinetics and dosing implications Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique.A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria.Malaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women.Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients.Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers.Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.Obstetric Pharmacokinetic Dosing Studies are Urgently Needed.Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action.Treatment regimens for pregnant women with falciparum malaria.Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.Use of artemether-lumefantrine to treat malaria during pregnancy: what do we know and need to know?Pharmacokinetic considerations for use of artemisinin-based combination therapies against falciparum malaria in different ethnic populations.Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis.Population pharmacokinetics of artemether, dihydroartemisinin and lumefantrine in Rwandese pregnant women treated for uncomplicated malaria Malaria in pregnancy

P2860

Q28079877-9118D447-44DC-470F-9B4C-479306B60240 Q33710687-C40FF7DC-F6D2-41DA-88DF-A745E7B8988F Q34034413-E74AB71E-F63A-4344-BEFA-55C7C2BF6DFB Q34058351-07179C47-0C43-4226-81F0-58779E89D4DB Q34331026-08FACC28-66E4-4ABD-A247-8ED667F9EFE6 Q34433106-BFAC3342-0D85-4966-80A5-68A20FD8BF27 Q34456393-AF75ED42-92DF-4822-8227-675D33361D6A Q34953705-7D22C165-14AE-4AB9-994B-D1DDBFAA3DF1 Q35224221-1B0B4BA7-8610-4154-BC57-AF5B6233C6AA Q35286119-CC8B8E26-D76A-4A5E-BF9D-5D92317F2C63 Q36348696-2F0D3519-DB03-4E41-A7DA-D439F49B9C5F Q36552289-EC7E3ABC-61DD-4FF4-B905-0E8C3991372D Q36644765-F24F35CD-AAEB-4366-BAEE-2022E4038025 Q36898678-BEAAB40E-5DCF-45D7-BD9B-C0893E5D8828 Q37038270-E4B349E2-A958-4A0E-AF76-A30388F1AED8 Q37193141-55D94691-5CB9-4CAB-BBD0-BA0C7E8DB7B9 Q37263818-F29223E1-0063-4FF5-BB3B-7F9E24415A03 Q37575742-89CAE3E1-80B3-4ACD-A737-0671C4769271 Q38712611-86A3A431-E841-4243-8AFF-C54FF1616C62 Q38870452-C5E6ABF3-2FEF-4545-A446-793FDE5408BC Q38905356-889D6D01-95C0-4A48-9216-25A31958650C Q42712939-32FE8FB4-5C87-422E-9A46-5040682716CE Q46405195-AA499857-4C66-49EA-B0EA-27633DFC2D08 Q55449589-6A19768F-DF7C-4076-96FA-391CBC43B871 Q56354961-9F3539A1-1B3B-4535-9FDC-B47656C3A8E8 Q56421802-69676562-F494-498B-A43F-3CFD55B7CC05

P2860

Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda

http://www.wikidata.org/entity/Q36411652

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Population pharmacokinetics of ...... m falciparum malaria in Uganda

@ast

Population pharmacokinetics of ...... m falciparum malaria in Uganda

@en

type

label

Population pharmacokinetics of ...... m falciparum malaria in Uganda

@ast

Population pharmacokinetics of ...... m falciparum malaria in Uganda

@en

prefLabel

Population pharmacokinetics of ...... m falciparum malaria in Uganda

@ast

Population pharmacokinetics of ...... m falciparum malaria in Uganda

@en

P1433

Q36411652-FDEB6EC2-6302-4CC0-B331-AC42B6D58515

P1476

Q36411652-4F687A3A-71C9-43EA-B56E-6862433A85FD

P2093

Q36411652-2C1DCF20-5D48-4E5D-A496-D64D51957223

Q36411652-4381F67E-659F-4846-8DFF-7AD2A7FAD4F6

Q36411652-4EDEAC3D-914F-4050-BEF1-4921FA2E1611

Q36411652-87A8C0E0-FD96-4B12-9AE4-742552F031B9

Q36411652-9EB80328-DD4C-4958-89EA-9F68857C37C3

Q36411652-A4F778E8-1CC8-4B95-A141-C188D46A9A63

P2860

Q36411652-0659FAC7-BCDA-436D-9588-6FA35B3503EC

Q36411652-1346ABA5-8F8B-487D-AB53-47B4EA09DDD0

Q36411652-21D774D4-1877-4368-9C33-C7BD01C094B7

Q36411652-23C33190-5F95-45A1-B9E9-FA7B1E6B42DF

Q36411652-3B543842-31C7-449F-B7E2-463E59A5A789

Q36411652-4113B344-80DE-4FDB-9B4B-D1AB8754B34D

Q36411652-424CF4F9-16AD-477E-B5ED-4D5503312678

Q36411652-450A0953-CFED-4B5E-9674-28CD05BA0AF1

Q36411652-45159418-2955-414A-B29B-DAA41271710B

Q36411652-45E898D7-D369-4018-9CD3-C90758CBF132

P2888

Q36411652-72E8B30E-489F-4059-B818-961D09CCEFAE

P304

Q36411652-17ECDF22-9C57-42B9-8664-470A16DB6C37

P31

Q36411652-2495A48F-1B2E-4762-A589-79CEF233B8EC

P356

Q36411652-59AA8A1D-698A-4467-A151-A2040159D3A4

P478

Q36411652-8030BB3C-4CE9-4492-A6DB-C8E7B54117DD

P50

Q36411652-1DC40635-1583-4C63-8606-69CB2A1637CF

Q36411652-2DF76BDF-0B65-4524-8421-16006A7022E3

Q36411652-303C8E16-D764-42B1-9AB4-1F63948956AD

Q36411652-769D7A51-9B32-4EF3-BBA6-B9D8444F736C

Q36411652-B8294E57-5C72-43C9-8CB5-E213F526E639

Q36411652-BC63120C-F380-492F-9573-A74E6CA6286E

P577

Q36411652-452D7FE4-4405-4EBD-91C3-153F2258CF2D

P5875

Q36411652-D19B4208-0BF8-45F6-8E1A-A96A7459225B

P6179

Q36411652-825BDAEC-8118-46F8-915C-3FF31A9C67E5

P698

Q36411652-DFBF6770-7F9C-4F04-82B9-862628C25AD3

P921

Q36411652-494B4B70-243E-4E2E-A13F-A00E69613BD6

Q36411652-73E2B0B0-70D7-41A5-AE2F-CFDDDB3D526D

Q36411652-A3B22FBE-6FB1-4743-BEE6-CCD6069000D2

Q36411652-B37EB40A-6152-46E0-9C82-35CD3A9C0CFA

P932

Q36411652-1620304C-C054-4468-97AD-D4031AFEA878

P356

1475-2875-11-293

P1433

Malaria Journal

P1476

Population pharmacokinetics of ...... m falciparum malaria in Uganda

@en

P2093

Eleanor Turyakira

http://www.w3.org/2001/XMLSchema#string

Mehul Dhorda

http://www.w3.org/2001/XMLSchema#string

Niklas Lindegardh

http://www.w3.org/2001/XMLSchema#string

Nitra Nuengchamnong

http://www.w3.org/2001/XMLSchema#string

Patrice Piola

http://www.w3.org/2001/XMLSchema#string

Sulaiman Muwanga

http://www.w3.org/2001/XMLSchema#string

P2860

Artemisinin combination therapy for vivax malaria

Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial

A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy

Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models.

Ways to fit a PK model with some data below the quantification limit.

Perl-speaks-NONMEM (PsN)--a Perl module for NONMEM related programming.

Likelihood based approaches to handling data below the quantification limit using NONMEM VI.

PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

Handling data below the limit of quantification in mixed effect models.

Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study

P2888

1475-2875-11-293

P304

293

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2875-11-293

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas John White

François H Nosten

Nicholas P J Day

Philippe J. Guerin

Frank Kloprogge

P577

2012-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230721605

http://www.w3.org/2001/XMLSchema#string

P6179

1019974843

http://www.w3.org/2001/XMLSchema#string

P698

22913677

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum

pregnancy-associated malaria

P932

3502166

http://www.w3.org/2001/XMLSchema#string